Deciphera shares skyrocket as cancer drug improves progression-free survival

Deciphera Pharmaceuticals Inc's shares more than doubled on Tuesday after the drugmaker said its treatment helped stomach cancer patients live longer without their disease worsening in a late-stage study. Reuters Health News

https://en.ojaghia.vet

Leave a Reply

Time limit is exhausted. Please reload CAPTCHA.